Schonfeld Strategic Advisors’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $627K | Buy |
+14,530
| New | +$627K | ﹤0.01% | 1392 |
|
|
2024
Q4 | – | Sell |
-67,831
| Closed | -$1.73M | – | 1927 |
|
|
2024
Q3 | $1.73M | Buy |
67,831
+32,450
| +92% | +$826K | 0.01% | 822 |
|
|
2024
Q2 | $896K | Buy |
+35,381
| New | +$896K | 0.01% | 1130 |
|
|
2024
Q1 | – | Sell |
-125,939
| Closed | -$5.08M | – | 1878 |
|
|
2023
Q4 | $5.08M | Sell |
125,939
-41,180
| -25% | -$1.66M | 0.03% | 463 |
|
|
2023
Q3 | $4.41M | Buy |
+167,119
| New | +$4.41M | 0.03% | 499 |
|
|
2023
Q2 | – | Sell |
-18,579
| Closed | -$308K | – | 1980 |
|
|
2023
Q1 | $308K | Buy |
+18,579
| New | +$308K | ﹤0.01% | 1343 |
|
|
2022
Q4 | – | Sell |
-97,519
| Closed | -$970K | – | 2508 |
|
|
2022
Q3 | $970K | Sell |
97,519
-79,507
| -45% | -$791K | 0.01% | 1271 |
|
|
2022
Q2 | $1.61M | Sell |
177,026
-39,274
| -18% | -$357K | 0.02% | 756 |
|
|
2022
Q1 | $2.2M | Buy |
216,300
+153,400
| +244% | +$1.56M | 0.02% | 649 |
|
|
2021
Q4 | $1.05M | Buy |
62,900
+44,700
| +246% | +$745K | 0.01% | 853 |
|
|
2021
Q3 | $853K | Sell |
18,200
-28,687
| -61% | -$1.34M | 0.01% | 948 |
|
|
2021
Q2 | $2.86M | Buy |
46,887
+1,750
| +4% | +$107K | 0.03% | 582 |
|
|
2021
Q1 | $2.78M | Buy |
45,137
+36,211
| +406% | +$2.23M | 0.03% | 558 |
|
|
2020
Q4 | $635K | Sell |
8,926
-14,815
| -62% | -$1.05M | 0.01% | 924 |
|
|
2020
Q3 | $890K | Buy |
23,741
+10,395
| +78% | +$390K | 0.02% | 691 |
|
|
2020
Q2 | $436K | Buy |
+13,346
| New | +$436K | 0.01% | 816 |
|